Back to News
Market Impact: 0.18

Best Growth Stocks to Buy for September 24th

Source: zacks.com

Analyst EstimatesAnalyst InsightsEnergy Markets & PricesHousing & Real EstateHealthcare & Biotech
Best Growth Stocks to Buy for September 24th

Zacks highlighted National Energy Services Reunited (NESR), KE Holdings (BEKE), and Centene (CNC) as Zacks Rank #1 growth stocks. Current-year consensus EPS estimates rose 4.6% for NESR, 10.2% for BEKE, and 40.9% for CNC over the past 60 days. The item is favorable analyst commentary but is unlikely to have broad market impact.

Analysis

This is low-information, mechanically promotional research rather than a fundamental catalyst; estimate revisions alone are not investable without identifying whether they reflect recurring operating improvement, one-time items, or consensus catch-up after prior guidance. The highest near-term sensitivity is likely CNC because a large earnings revision can alter the perceived earnings trough, but managed-care multiples will remain anchored to medical-cost trend, Medicare Advantage reimbursement, and regulatory scrutiny rather than a ranking signal.

For BEKE, upward estimates are only durable if existing-home transaction volumes and monetization per transaction improve together. A housing-policy or mortgage-demand bounce can drive a sharp 1-3 month ADR rerating, but it remains vulnerable to renewed Chinese property stress, weak secondary-market liquidity, and ADR risk; domestic peers such as 2082.HK provide a cleaner read-through than U.S. housing proxies.

NESR is a more idiosyncratic Middle East oil-services exposure than a broad crude beta. Its 6-18 month upside depends on Saudi/UAE and regional customer capex staying elevated, while utilization, pricing, receivables collection, and customer concentration matter more than spot oil; a regional capex pause would compress service margins before revenue visibly rolls over. No broad sector trade is warranted from the article alone.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.35

Ticker Sentiment

BEKE0.58
CNC0.68
NESR0.50

Key Decisions for Investors

  • CNC: maintain a watch-list long only into the next earnings release if management reaffirms full-year medical-cost and Medicare Advantage margin assumptions; target a 10-15% rerating over 3-6 months if EPS durability is validated. Exit on a material MLR increase, guidance cut, or adverse reimbursement/regulatory development.
  • BEKE: consider a small tactical long versus short KWEB for 1-3 months only if China existing-home sales and transaction volumes show sequential improvement; this isolates company execution from broad China internet beta. Size modestly given property-policy and ADR tail risk; invalidate on renewed transaction-volume deterioration.
  • NESR: do not chase estimate momentum. Set an alert for quarterly backlog, regional rig/activity growth, and DSO/receivable disclosures; initiate only if revenue growth is accompanied by stable-to-higher EBITDA margin and cash conversion. A long NESR versus short SLB can express Middle East activity resilience, but only after those data confirm it.
  • Treat all three as earnings-confirmation candidates rather than event-driven positions; there is no independently verifiable catalyst in the source sufficient to justify immediate directional risk.

More News

From AllMind Research

Browse all research